# Kura Oncology, Inc.: Form 8-K, filed Nov 13, 2025

- Company: [Kura Oncology, Inc.](/companies/kura.md) (CIK 1422143)
- Form: 8-K
- Filed: 2025-11-13
- Accepted by EDGAR: Nov 13, 2025, 16:27 ET
- Period: 2025-11-13
- Accession: 0001193125-25-280255
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1422143/000119312525280255/d159173d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1422143/000119312525280255/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1422143/000119312525280255/d159173d8k.htm

Filed Nov 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-280255. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.